Smith & Nephew plc (SN) Given Average Rating of “Hold” by Analysts
Shares of Smith & Nephew plc (LON:SN) have been assigned an average rating of “Hold” from the eleven brokerages that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is GBX 1,391.33 ($17.79).
Several brokerages recently commented on SN. Numis Securities lifted their target price on shares of Smith & Nephew from GBX 1,350 ($17.26) to GBX 1,480 ($18.92) and gave the stock an “add” rating in a report on Thursday, July 26th. Deutsche Bank reiterated a “sell” rating on shares of Smith & Nephew in a report on Monday, July 30th. UBS Group downgraded shares of Smith & Nephew to a “neutral” rating and dropped their target price for the stock from GBX 1,470 ($18.79) to GBX 1,340 ($17.13) in a report on Wednesday, August 8th. Berenberg Bank restated a “hold” rating and issued a GBX 1,370 ($17.51) price target on shares of Smith & Nephew in a research report on Monday, May 14th. Finally, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,515 ($19.37) price target on shares of Smith & Nephew in a research report on Thursday, May 3rd.
In related news, insider Erik Engstrom bought 249 shares of the company’s stock in a transaction on Thursday, August 23rd. The stock was bought at an average cost of GBX 1,380 ($17.64) per share, with a total value of £3,436.20 ($4,392.43). Also, insider Graham Baker bought 19 shares of the company’s stock in a transaction on Thursday, August 2nd. The stock was bought at an average cost of GBX 1,331 ($17.01) per share, with a total value of £252.89 ($323.26).
The company also recently declared a dividend, which will be paid on Wednesday, October 31st. Shareholders of record on Thursday, October 4th will be given a $0.14 dividend. The ex-dividend date is Thursday, October 4th. This represents a yield of 0.77%.
About Smith & Nephew
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Story: Technical Analysis of Stocks, How Can It Help
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.